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ABSTRACT The ﬁrst stage in hemostasis is the binding of the platelet membrane receptor glycoprotein (GP) Ib-IX complex to
the A1 domain of von Willebrand factor in the subendothelium. A bleeding disorder associated with this interaction is platelet-
type von Willebrand disease, which results from gain-of-function (GOF) mutations in amino acid residues 233 or 239 of the GP
Iba subunit of GP Ib-IX. Using optical tweezers and a quadrant photodetector, we investigated the binding of A1 to GOF and
loss-of-function mutants of GP Iba with mutations in the region containing the two known naturally occurring mutations. By
dynamically measuring unbinding force proﬁles at loading rates ranging from 200–20,000 pN/s, we found that the bond
strengths between A1 and GP Iba GOF mutants (233, 235, 237, and 239) were signiﬁcantly greater than the A1/wild-type GP Ib-
IX bond at all loading rates examined (p , 0.05). In addition, mutants 231 and 232 exhibited signiﬁcantly lower bond strengths
with A1 than the wild-type receptors (p , 0.05). We computed unloaded dissociation rate constant (k0off) values for interactions
involving mutant and wild-type GP Ib-IX receptors with A1 and found the A1/wild-type GP Ib-IX k0off value of 5.47 6 0.25 s
1 to
be signiﬁcantly greater than the GOF k0off values and signiﬁcantly less than the loss-of-function k
0
off values. Our data illustrate the
importance of the bond kinetics associated with the VWF/GP Ib-IX interaction in hemostasis and also demonstrate the drastic
changes in binding that can occur when only a single amino acid of GP Iba is altered.
INTRODUCTION
To achieve hemostasis, platelets must adhere to the exposed
subendothelial matrix in damaged blood vessels. This initial
adhesion is mediated by the platelet glycoprotein (GP) Ib-
IX-V receptor complex binding to the glycoprotein von
Willebrand factor (VWF) present on the exposed subendo-
thelium. The GP Ib-IX-V complex is comprised of four
subunits: GP Iba, GP Ibb, GP IX, and GP V (Fig. 1). GP Iba
is linked to GP Ibb through a disulﬁde bond, whereas GP IX
and GP V are noncovalently associated with GP Ib. GP V is
not necessary for binding to VWF, but it is a substrate for
thrombin (Dong et al., 1997) and appears to function as an
ancillary collagen receptor (Moog et al., 2001). GP Iba con-
tains the binding sites not only for VWF but also for Mac-1,
P-selectin, thrombin, high molecular kininogen, and Factor
XII (Berndt et al., 2001).
VWF is a large glycoprotein, the mature subunit con-
sisting of 2050 amino acid residues, which is primarily
stored in the a-granules of platelets and the Weibel-Palade
bodies of endothelial cells, from which it is released upon
cell activation. VWF contains three consecutive, homolo-
gous A domains, with the A1 domain containing the GP Ib-
IX binding site (Sadler, 1998). After GP Ib-IX-V has bound
to VWF, a cascade of interactions ensues that results in
platelet activation and subsequent aggregation, ultimately
leading to the formation of a platelet-rich thrombus. These
interactions include secretion of agonists (e.g., ADP) by
platelets, elevation of cytosolic Ca21, and Ca21-dependent
activation of GP IIb-IIIa (Kroll et al., 1996; Ruggeri, 1997;
Goto et al., 1998).
When unusually large VWF multimers are released from
endothelial cells, they are processed into smaller and less
adhesive plasma forms by the ADAMTS-13 enzyme
(Gerritsen et al., 2001;Fujikawa et al., 2001). Normally the
plasma form of VWF does not interact with GP Ib-IX-V;
however, plasma VWF and GP Ib-IX-V will interact with
each other when they are exposed to pathologic shear stress
such as those in arteries occluded by atherosclerotic plaque.
The presence of various exogenous modulators can also
induce binding in vitro when high shear stress is absent
(Berndt et al., 1992).
The crystal structure of the GP Iba/VWF complex reveals
two main contact areas bridged by an area of solvated charge
interaction (Huizinga et al., 2002). The ﬁrst and largest
contact area, between VWF and GP Iba, involves leucine-
rich repeats 5–8 and the COOH-terminal ﬂank interacting
with the top portion of the A1 domain. The second contact
area, between a part of the NH2-terminal domain and the
leucine-rich repeat 1 of GP Iba, involves three portions of
the bottom face of the A1 domain. When GP Iba interacts
with VWF, the loop from amino acid residue 227 to residue
241 in the COOH-terminal ﬂank of GP Iba (Fig. 1 B) is
hypothesized to change conformation. Gain-of-function
(GOF) mutations in this loop can lead to platelet-type von
Willebrand disease (ptVWD), where afﬂicted individuals are
thrombocytopenic and have a propensity to bleed easily.
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Speciﬁcally, mutations of glycine (Miller et al., 1991) or
methionine (Russell and Roth, 1993) at residues 233 and
239, respectively, to valine (Fig. 1 B) cause the platelet re-
ceptor to bind VWF more readily (Tait et al., 2001).
Although mutations most likely modulate the afﬁnity of GP
Iba for VWF in ptVWD platelets, avidity modulation that
results in an increased number of bonds could also be
playing a role in the excessive VWF binding. The increased
propensity to bleed in individuals with ptVWD is thought to
result from rapid clearance from the plasma of the highest
molecular weight multimers of VWF, which are particularly
effective in mediating platelet adhesion (Arya et al., 2002).
In vitro, the platelets of patients with ptVWD bind VWF at
much lower modulator concentrations than are required to
induce VWF binding to normal platelets (Miller and Castella,
1982; Weiss et al., 1982).
Several previous studies have investigated VWF adhesion
to GP Iba containing the ptVWD mutations expressed in
heterologous cell lines. Dong et al. (2000) observed that
transfected cells expressing the GOF mutants rolled signiﬁ-
cantly more slowly than wild-type cells over immobilized
VWF under ﬂow, required lower modulator concentrations
to bind VWF, and supported cell adhesion at much lower
surface-coating densities of VWF. Tait et al. (2001) ex-
amined the VWF-binding ability of similar mutants using
microcapillary tubes and found that ristocetin-mediated
VWF/mutant GP Ib-IX adhesion was greater than VWF/
wild-type GP Ib-IX adhesion in terms of cell tethering to the
VWF-coated substrate, slower cell rolling velocity, and
decreased cell detachment with increasing shear rate. In
addition, Doggett et al. (2003) have investigated the
interaction between ptVWD platelets and A1 using a ﬂow
chamber system, and found that the GP Iba-233 mutation
promoted and stabilized platelet adhesion at shear rates that
do not support adhesion between wild-type GP Ib-IX-V and
VWF. Although the Doggett et al. study was useful in
characterizing the interaction between ptVWD GP Ib-IX-V
receptors and VWF at various shear rates, it employed bulk-
ﬂow measurement techniques as opposed to single-molecule
methods. In this study, we used optical tweezers to
investigate the effect of substituting valine for other amino
acids in GP Iba on binding A1 at a single-bond level over
a wide range of loading conditions. With single-molecule
measurements, one can begin to understand important
physiological functional ﬂuctuations that may not be
apparent by observing average values of physical quantities.
For example, one is able to distinguish whether the afﬁnity or
avidity of a particular bond is modiﬁed by an external
stimulus (Arya et al., 2003).
Using a Chinese hamster ovary cell model that expresses
several ptVWD mutant receptors as part of recombinant
GP Ib-IX complexes, we aim to explore the intricacies of
VWF binding-afﬁnity modulation that occur when mutations
are introduced into the region of GP Iba associated with
ptVWD. Measurements of forces to break the bonds between
A1 and GP Iba at various loading rates allows subsequent
investigation of molecular unbinding mechanics through
computation of the dissociation constants for the interactions
between A1 and mutant or wild-type GP Ib-IX receptor
complexes.
MATERIALS AND METHODS
Cells expressing GP Ib-IX complexes
The method for preparing the cells that express mutant receptors used in this
study has been previously described (Dong et al., 2000). Brieﬂy, six
mutations were created in which each codon for nonvaline residues within
a region spanning Lys231–Met239 was converted to a valine codon. The
mutated GP Iba cDNAs were then transfected into Chinese hamster ovary
FIGURE 1 (A) The GP Ib-IX-V complex is composed of four subunits:
GP Iba, GP Ibb, GP IX, and GP V. GP Iba is the subunit responsible for
binding to VWF A1 domain. (B) Diagram illustrating the GP Iba C-terminal
ﬂank disulﬁde loops. The two mutations associated with ptVWD involve the
conversion of nonvaline residues to valines at amino acid residues 233 and
239.
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(CHO) bIX cells (which stably express GP Ibb and GP IX) using
Lipofectamine (Invitrogen, Carlsbad, CA). Since the GP V subunit is not
required for the VWF/GP Ib-IX interaction, it was not included in our
transfection system. The mutant cells used in the study expressed GP Ib-IX
complexes with GP Iba mutations at residues 231, 232, 233, 235, 237, and
239. CHO abIX cells, which expressed wild-type GP Iba, were also
prepared and used to investigate A1 binding. CHO bIX cells were used as
negative controls since they do not bind VWF. The diameter of the CHO
cells was typically 10 mm.
Preparation of A1 and protein-coated beads
The interactions of the A1 domain with the different GP Ib-IX mutants were
investigated. Recombinant VWF A1 domain was produced using Escher-
ichia coli by a previously described method (Cruz et al., 1993). It is
important to note that the recombinant VWF A1 domain used in our study
was not glycosylated. Glycosylation, in the isolated domain and in the intact
protein, appears to negatively modulate the binding of VWF to GP Iba. For
example, Cruz et al. (1993) have shown that glycosylation of the VWF A1
domain increases its solubility but reduces its afﬁnity for GP Ib-IX. These
investigators showed that the afﬁnity of glycosylated A1, produced in CHO
cells, for platelet GP Ib-IX was threefold lower when compared to the
nonglycosylated version. Our own optical tweezers-based study (Arya et al.,
2002) showed that isolated, nonglycosylated A1 and unusually large VWF,
which presumably contained glycosylated A1, adhered to GP Ib-IX with
similar bond strengths. These studies all suggest that in the isolated A1
domain, the nonglycosylated form assumes the active conformation present
in unusually large VWF, or becomes induced when VWF binds collagen or
is activated by ristocetin. Consistent with this ﬁnding, early studies showed
that desialylation of intact plasma VWF produced a form capable of binding
and activating platelets spontaneously (De Marco and Shapiro, 1981).
Activation of VWF by either shear stress, collagen binding, desialylation, or
the nonphysiological modulators ristocetin and botrocetin, is necessary for
its binding to GP Iba and therefore for studies of that interaction. The
nonglycosylated form of A1 thus provides a useful reagent for the studies
of this interaction, and numerous studies have used A1 produced from E.
coli to investigate structural and functional attributes of VWF. For example,
Emsley et al. (1998) determined the crystal structure of A1 domain using
nonglycosylated A1 from E. coli. In addition, Miyata and Ruggeri (1999)
studied A1/GP Iba adhesion under ﬂow using nonglycosylated A1 from E.
coli.
Polystyrene beads (Polysciences, Warrington, PA) with a diameter of 2.0
mm were coated with A1 according to the following procedure. Single drops
of bead suspensions were added to tubes containing A1 at a concentration of
either ;10 or 100 mg/ml in citrate phosphate buffer. The beads and A1
domain were then incubated for 1 h at room temperature with gentle mixing
on an aliquot shaker. The suspension was subsequently centrifuged for 2 min
in an Eppendorf microcentrifuge at 15,000 rpm. The supernatant was
removed, and the beads were resuspended by vortex in Dulbecco’s
phosphate-buffered saline solution (pH 7.3) containing 10 mg/ml bovine
serum albumin, 1 mg/ml sodium azide, and 5% glycerol. The beads were
then washed in 1 ml Dulbecco’s phosphate-buffered saline solution, in-
cubated for 30 min, centrifuged for 2 min, and resuspended in 0.5 ml of
Dulbecco’s solution.
Optical tweezers setup and measurements of
time-resolved unbinding forces
We used a titanium-sapphire laser (Ti:sapph) (3900 S, Spectra-Physics,
Santa Clara, CA) tuned to 830 nm in our optical tweezers setup (Fig. 2).
Light-induced damage to cells varies with the incident wavelength, but little
or no damage has been demonstrated at 830 nm in an optical trap (Neuman
et al., 1999;Leitz et al., 2002).
The Ti:sapph laser was pumped by a solid-state, frequency-doubled
neodymium yttrium vanadate (Nd:YVO4) laser operating at a wavelength of
532 nm (Millennia V, Spectra-Physics). The laser light then passed through
an attenuator (925B, Newport Electronics, Irvine, CA) used to control the
beam intensity. An external dichroic mirror placed just before the bottom
entrance port allowed transmission of the laser light into an inverted
microscope (Axiovert S100TV, Carl Zeiss, Jena, Germany). The laser light
was focused by a high numerical aperture (1.3) objective lens onto
a diffraction-limited spot to form an optical trap (Ashkin et al., 1986).
A glass-bottom culture dish (P35GC-0-10-C, MatTek, Ashland, MA)
was used to hold the cells and beads. A 10-mm-diameter German glass no. 0
coverslip was located in the center of the 35-mm dish. Using a micropipette,
we added 100 mL of cells and 5 mL of beads to the dish, which was left
exposed to the air to prevent heating of the sample by the laser. The cell/bead
suspension could be left uncovered for 1 h before evaporation became
signiﬁcant. The cell chamber was illuminated from the top with white light
for visualizing the specimens. The external dichroic mirror reﬂected the light
,650 nm toward a beam splitter, which transmitted 10% of the light to
a charged-coupled device (CCD) camera (CCD 100, DAGE-MTI, Michigan
City, IN) for imaging purposes. Due to slight leakage of the laser beam into
the imaging path, an infrared ﬁlter was placed before the beam splitter
to pass all light ,700 nm. The remaining 90% of the light was sent to
a quadrant photodetector (Hamamatsu, S4939, Somerville, NJ), mounted on
a micrometer-controlled stage, used for measurements of dynamic un-
binding force between the receptor and its ligand.
FIGURE 2 Optical tweezers setup. Light from a tita-
nium-sapphire laser (l¼ 830 nm) is reﬂected by a dichroic
mirror and focused by a high-numerical-aperture (1.3)
objective lens of an inverted microscope to form an optical
trap. A charge-coupled device camera collects 10% of the
light for image visualization, and a quadrant photodetector
uses the remaining light for dynamically monitoring the
displacement of the bead from the trapping center during
the bond rupture process. The CHO cell and A1-coated
bead are in a solution chamber mounted onto a piezoelec-
trically driven translational stage used to position the cell at
an appropriate distance from the trapped bead.
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We use the dynamic displacement of the trapped bead from the trapping
center in response to an external force application (e.g., molecular forces
acting upon the trapped bead) as a technique to obtain time-resolved force
measurements. Speciﬁcally, we project the change in the shadow of the
trapped 2-mm bead by a 153 eyepiece in response to external force ap-
plication onto the surface of the quadrant photodetector, generating a voltage
signal on each of its four quadrants (V1–V4), and relate the voltage to bond
loading and, hence, to the unbinding force. The solution chamber containing
cells was mounted onto a piezoelectrically driven translational stage
(P-527.3CL, Physik Instrumente, Waldbronn, Germany). Movement of the
piezoelectric stage was controlled by a function generator (Stanford Re-
search Systems, DS345, Sunnyvale, CA). The resolution of the piezoelectric
stage was 10 nm in the x and y directions and 2 nm in the z direction (laser-
beam propagation direction).
The analog photodetector output voltage resulting from the movement of
a trapped bead during bond rupture were ampliﬁed by a circuit (QP50-6SD,
Paciﬁc Silicon Sensor, Westlake Village, CA) and digitized with an A-D
converter (Wavebook512, Iotech, Cleveland, OH). The sampling frequency
for all experiments was 50 kHz. The bandwidth of the detection system was
257 kHz and the signal/noise ratio (SNR) was 120. The SNRwas determined
experimentally by analyzing the variation in the photodetector voltage signal
of a bead responding to movement of the piezoelectric stage driven by a
triangular waveform of 1 Hz. The SNR was then computed as the back-
ground subtracted mean of the signal divided by the mean of the standard
deviation of the signal. The drift performance of the detection system was
found to be 15 nm/min. We analyzed the digital signals by a LabView virtual
instrument to compute the dynamic unbinding forces.
Calibration procedure
During the force calibration process, a bead was trapped and different ﬂuid
velocities were applied through the use of the piezoelectric stage to induce
a viscous drag force on the trapped bead. A triangular waveform was used to
drive the stage, and the frequencies applied ranged from 1 to 6 Hz (Ermilov
and Anvari, 2004). The forces induced using these frequencies were in the
same range as the rupture forces measured in our experiments. The con-
tinuous change in the shadow of the trapped bead was projected onto the
surface of the quadrant photodetector generating a voltage signal on each
of its four quadrants (V1–V4). Bead displacement from the trapping center in
the x direction (corresponding to the direction of ﬂuid ﬂow) in response to
the viscous drag force was characterized by the voltage difference Vx ¼
(V1 V4)1 (V2 V3). For a given laser power, Vx was recorded at different
ﬂuid velocities, which corresponded to different trapping forces. The forces
were computed by using a modiﬁed version of Stokes law,
F ¼ 6phvr
1 9
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h
 
1
1
8
r
h
 3
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r
h
 4
 1
16
r
h
 5; (1)
in which h is the solution viscosity, v is the stage velocity, r is the bead
radius, and h is the distance between the center of the bead and the coverslip.
The denominator represents the correction factor that must be used to correct
the drag force due to the sphere’s proximity to the coverslip (Svoboda and
Block, 1994).
In this study, we performed the calibration when the pumping laser was
set at a maximal output of 5 W, which resulted in Ti:sapph laser power of
310 mW after the microscope objective. Calibration of the bead
displacement and trapping force as a function of Vx for a 2-mm-diameter
polystyrene bead trapped at h ¼ 10 mm from the coverslip are shown in Fig.
3. The height was determined by focusing the objective on surface-bound
debris and then moving the objective up 10 mm using the ﬁne-focus
adjustment of the microscope. The light level during bond rupture
experiments was kept at the same level as in the calibration procedure.
The relationship between photodetector voltage and bead displacement was
determined to be ;0.03 V/mm by immobilizing the bead on the coverslip
and moving the stage to a distance equal to the diameter of the bead (2 mm).
Since our experiments required the bead to be 10 mm above the coverslip,
during the voltage-displacement calibration procedure we made sure to keep
the bead in the same focal plane that was used in the trials to determine
rupture force. The value of 0.03 V/mmwas multiplied by the slope of the line
in Fig. 3 B to compute the trap stiffness (;200 pN/mm). In Fig. 3 B, the force
values were obtained by moving the piezoelectric stage at a known velocity,
and applying Stokes law.
Interaction of A1 and GP Ib-IX
The A1/GP Ib-IX time-resolved rupture force was measured using the
quadrant photodetector, which recorded the change in shadow of the trapped
bead projected on its quadrants during unbinding experiments. The CHO cell
was placed in the solution chamber 10min before an experiment to allow ﬁrm
adhesion to the coverslip. We optically trapped a bead coated with A1 at
a distance of 4 mm from the cell, and moved the transfected cell toward the
trapped bead at a constant velocity by using the piezoelectrically driven stage.
The cell was then immediately retracted from the trapped bead at the same
velocity. As the piezoelectric stage moved the cell, the photodetector
measured the amount of the change in the shadow of the trapped bead, which
was induced by displacement of the bead from the trap center. As bonds were
breaking and displacing the bead, a continuous curve of Vx against time was
obtained. The bead was recentered at the beginning of each experiment.
To account for the cell’s shadow on the photodetector, we subtracted the
retraction voltage measurements from the approach voltage measurements.
This procedure had to be performed since the cell’s contribution to the
photodetector voltage signal was many times that of the bead, depending on
the distance between the bead and the cell. Using the curve depicting the
photodetector voltage difference in the approach and retraction phases
together with the trapping force calibration curve (Fig. 2 B), the dynamic
bond rupture force was measured.
FIGURE 3 Calibration of bead displacement and force as a function of
photodetector differential output voltage, Vx. (A) There was a linear relation-
ship between bead displacment and Vx. (B) The linear relationship between
force and Vx yielded a slope of;6.2 pN/mV.
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To conﬁrm that the subtraction process was valid, we used 2.0-mm-
diameter ﬂuorescent beads (F-8826, Molecular Probes, Eugene, OR) with
peak excitation and emission wavelengths of 580 and 605 nm, respectively,
coated with A1. For ﬂuorescence excitation (XBO xenon short-arc lamp,
75 W), only the image of the trapped ﬂuorescent bead was projected on the
quadrant photodetector. In this way, the image of the cell did not inﬂuence our
force measurements. Fluorescence illumination passes through an excitation
ﬁlter (D535/50, Chroma Technology, Rockingham, VT) into the objective to
illuminate the trapped ﬂuorescent bead. The ﬂuorescent light emitted from the
bead was recollected by the objective, and separated from the excitation light
by the dichroic mirror. A ﬁlter (D606/55, Chroma Technology) was placed in
front of the quadrant photodetector to speciﬁcally select the ﬂuorescent light
from the bead. The forces for bond rupture using the subtraction method and
ﬂuorescent method were found to be comparable.
Velocities of 0.5, 1, 5, 10, 50, and 100 mm/s were investigated, and the
laser power remained constant regardless of pulling velocity. The loading
rates were computed by multiplying the pulling rate by the trap stiffness and
ranged from 200 to 20,000 pN/s. No exogenous modulator was required as
we have previously shown that immobilized A1 spontaneously binds to GP
Ib-IX (Arya et al., 2002).
Model of bond dissociation
The Bell model is used frequently to evaluate protein-protein interactions
under an applied load (Bell, 1978). Under the Bell model, an applied force F
distorts the energy landscape of a receptor-ligand complex. When a bond is
loaded, the activation barrier is lowered, and the bond will tend to break
faster than its unloaded counterpart. The lowering of the activation barrier
causes the dissociation rate constant, koff, to increase when the bond is
loaded. In the Bell model, the dissociation constant is exponentially related
to the applied force F by the equation
koffðFÞ ¼ k0offexp
F 3 xb
kBT
 
; (2)
where k0off is the unloaded (spontaneous) dissociation rate, kB is Boltzmann’s
constant (1.3807 3 1023 J/K), T is absolute temperature, and xb is the
distance between the bound state and transition state along the reaction
coordinate. Since the force on the bond is not applied instantaneously, one
can consider the load-dependent dissociation by incorporating the loading
rate into Eq. 2 and deriving the following equation,
F ¼ kBT
xb
3 ln
rxb
k
0
offkBT
 
; (3)
where r is a constant loading rate (Evans and Ritchie, 1997). This expression
predicts a linear relationship between rupture force and the logarithm of the
loading rate (Merkel et al., 1999; Tees et al., 2001).
Statistics
Each result is reported as the mean 6 SD. The error bars in all graphs
indicate standard deviation. The Student’s t-test was used to determine if
there were statistically signiﬁcant differences among the computed k0off
values and rupture force values.
RESULTS
Time-resolved measurements of unbinding forces
in wild-type and mutant and GP Ib-IX complexes
Time-resolved unbinding proﬁles for the A1/wild-type and
mutant GP Ib-IX interactions were recorded at loading rates
of 100, 200, 1,000, 2,000, 10,000, and 20,000 pN/s. Only the
forces in the x direction were analyzed since negligible
forces were observed in the y direction during the bond
detachment process. In Fig. 4 A, the wild-type CHO abIX
cell was moved away from the trapped A1-coated bead at
a pulling rate of 5 mm/s corresponding to an applied loading
rate of 1000 pN/s. The minimum value represents the rupture
force and corresponds to;21 pN. The force proﬁle for a trial
in which no adhesion occurred is shown in Fig. 4 B. One
should note the positive forces in both graphs that cor-
respond to impingement of the cell upon the trapped bead.
We also computed loading rates from the slope before the
point of rupture in the force-time graphs and found them to
be within 12% of applied values based on the product of
stage velocity and trapping stiffness (data not shown). Our
force proﬁles did not show multiple peaks characteristic of
FIGURE 4 Sample traces of A1/wild-type unbinding force proﬁle
acquired using quadrant photodetector. Graphs depict experiments in which
adhesion occurred (A) and did not occur (B). Proﬁles were obtained at 1000
pN/s.
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sequential breakage (Chen and Moy, 2000), but rather one
large peak suggesting that the bonds broke simultaneously.
No adhesion was observed between the CHO bIX cells
(expressing GP Ibb and GP IX, but not GP Iba) and the beads
coated with A1 domain, conﬁrming that the A1 domain binds
exclusively to the GP Iba. It is highly improbable that the
measured forceswere associatedwith the removal of adsorbed
A1 from the polystyrene beads. Gergely et al. (2000) have
studied the process of adsorption and found that, within
milliseconds, the force required to rupture the nonspeciﬁc
adhesion between ﬁbronectin and hydrophobic silica was
;200 pN. In addition, the adhesive forces between proteins
and polystyrene after long-term adsorption are several orders
of magnitude greater than the forces we have measured
(Sagvolden, 1999).
Although passive adsorption has frequently been used to
immobilize ligands onto surfaces in previous studies (Gergely
et al., 2000), potential problems are associated with this
method. When ligands are passively immobilized, the mole-
cules can attach to the surface in many different orientations.
If the orientation is not correlated with the speciﬁc receptor-
ligand interaction, the functionality of the ligand could be
compromised (Davies et al., 1994). Instead of passive ad-
sorption, others have used antibodies to attach ligands to
surfaces. For example, in their study of selectin-leukocyte
interactions, Hanley et al. (2004) used anti-human IgG-Fc
monoclonal antibodies to functionalize molecular force probe
cantilevers. The cantileverswere subsequently incubatedwith
L- or E-selectin/IgG-Fc chimera protein to ensure proper
functional orientation of the selectin. In our study, at least
some of the immobilized A1 molecules were clearly func-
tional, since signiﬁcant A1/GP Ib-IX adhesion was ob-
served.
The plasma membrane of the CHO cells formed visible
tethers in 5% of our experiments. In the rare cases where
tethers did form, the forces were an order of magnitude
greater than the typical rupture forces. We do not include
results from experiments in which tethers formed.
Histograms of rupture forces for A1/wild-type GP Ib-IX
bonds obtained at loading rates ranging from 100 to 10,000
pN/s are shown in Fig. 5. We observed that the bond rupture
force for the interaction between the A1 domain and both
wild-type and mutant GP Ib-IX complexes increased loga-
rithmically with loading rate (Fig. 6). Using Eq. 3 in con-
junction with the force-loading rate data, we computed k0off
and xb values for the interactions between A1 and the mutant
and wild-type receptors (Table 1). Differences between the
k0off and xb values for the A1/wild-type GP Ib-IX and A1/
mutant GP Ib-IX interactions were all statistically signiﬁcant
(p , 0.05).
DISCUSSION
Platelets must adhere to subendothelial matrix proteins and
other activated platelets at sites of vascular injury to achieve
hemostasis and participate in subsequent vascular repair. The
ﬁrst step in hemostasis involves bond formation between the
platelet GP Ib-IX-V receptor complex and VWF. In addition
to mediating platelet adhesion, the GP Ib-IX-V complex on
the surface of the platelet also transduces signals required for
platelet activation (Kroll et al., 1991). One consequence of
these signals is to induce a ﬁbrinogen-binding conformation
of aIIbb3, which then mediates platelet aggregation. There is
also evidence that the binding of VWF to GP Ib-IX can
induce cytoskeletal reorganization in platelets under phys-
iological ﬂow conditions (Yuan et al., 1999). Although the
A1/GP Ib-IX interaction is critical in the process of hemo-
stasis formation, fundamental data regarding the mechanics
of this particular bond is lacking.
Under equilibrium conditions, all molecules in solution
will bond and dissociate without any applied force. How-
ever, an applied force on a bond reduces the rupture time to
less than the characteristic bond lifetime, toff, required for
spontaneous dissociation (Evans, 2001). The values for toff
FIGURE 5 Histograms depicting distributions of A1/wild-type GP Ib-IX
rupture forces. Superposed on the histograms are best-ﬁt curves used to
determine the most frequent rupture force. The loading rates were 100 pN/s
(A), 1000 pN/s (B), and 10,000 pN/s (C).
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vary widely for different types of bonds, but many biological
interactions have characteristic toff values ranging from 0.1–
1 s (Hanley et al., 2003; Chesla et al., 2000). It has been well
established that energetic barriers along the pathways for
dissociation determine bond lifetime, and these barriers will
be lowered if an external force is applied. Under the Bell
model, the rate of unbinding will increase exponentially with
force.
FIGURE 6 Rupture force as a function
of loading rate plot for the A1/wild-type
GP Ib-IX and mutant GP Ib-IX interac-
tions. The loading rates ranged between
100 and 20,000 pN/s. Mutants 231 and 232
were found to bind less strongly to A1 than
mutants 233, 235, 237, 239, and the wild-
type cells.
Dynamic Force Spectroscopy 4397
Biophysical Journal 88(6) 4391–4401
From our experimental data using A1 and wild-type CHO
abIX cells, we used the slope of the line relating force and
loading rate and determined k0off to be 5.47 s
1. Although we
are using the model associated with a single sharp energy
barrier (Evans and Ritchie, 1997), we are not excluding the
possibility that the A1/GP Ib-IX energy landscape has mul-
tiple transition states. For example, Zhang et al. (2002) ob-
served two distinct linear regimes in their LFA-1/ICAM-1
unbinding data, thereby indicating two activation barriers for
the interaction. Dissociation constantswere also computed for
the interactions between A1 and the mutant GP Ib-IX com-
plexes. The GOF mutants (233, 235, 237, and 239) all exhib-
ited k0off values ,5.47 s
1 whereas the two loss-of-function
mutants (231 and 232) both had k0off values .5.47 s
1.
Several previous studies have estimated k0off values for the
A1/GP Iba interaction using conventional binding assays.
From saturation binding experiments involving radiolabeled
VWF A1 domain, Miura et al. (2000) suggested that slow
intrinsic binding kinetics were responsible for rapid GP
Iba adhesion to VWF. Miura et al. reported a k0off value of
0.0038 s1 for the interaction between radiolabeled A1 and
GP Iba present on formalin-ﬁxed platelets. The k0off value
estimated by Miura et al. was three orders of magnitude less
than the value reported by us and the value of 3.45 s1
reported by Doggett et al. (2002), who studied the A1/GP
Iba interaction using a parallel-plate ﬂow chamber. It is
important to note that Miura et al. measured the kinetics of
binding between the receptor and ligand using gamma
radiation counting without any force applied to the bond. It is
clear that the presence of an applied force on the bond greatly
inﬂuences the kinetics. In a subsequent study, Doggett et al.
examined the 233 valine mutation associated with ptVWD
and computed k0off for the A1/mutant GP Ib-IX interaction to
be 0.67 s1 (Doggett et al., 2003). In addition, Kumar et al.
(2003) estimated the k0off values for the A1/wild-type GP Ib-
IX and A1/mutant 237 interactions using a parallel-plate
ﬂow chamber to be 5.66 s1 and 2.56 s1, respectively. As in
the aforementioned studies, our results indicate a decrease in
k0off values for the A1/mutant GP Ib-IX interactions in
comparison to the A1/wild-type GP Ib-IX interactions. It is
important to note Doggett et al. (2002) used platelets in their
experiments, whereas we used transfected CHO cells. In
addition, Kumar et al. (2003) independently estimated k0off
based on the duration of transient tethering events between
GP Iba and the A1-coated substrate under conditions of
hydrodynamic ﬂow. In contrast, our optical tweezers-based
assay was performed without any hydrodynamic ﬂow to
examine the kinetics of bond rupture at the single-molecule
level. It is important to note that both ﬂow chambers and
optical tweezers impose forces on the bonds but not nec-
essarily the same forces. These forces are clearly important
in many biological phenomena, including the immune re-
sponse and hemostasis, and from an evolutionary standpoint,
have most likely inﬂuenced the structures and functions of
the proteins associated with these processes.
We computed the Bell model parameter of xb for A1
binding to wild-type and mutated GP Ib-IX receptors. Al-
though our xb values are larger than those found for selectins
(Chen and Springer, 2001) and the xb values from the Kumar
and Doggett studies, we are conﬁdent that we are not ex-
tracting the receptor from the plasma membrane. In a pre-
vious study, we showed that the bond strength between
plasma VWF and GP Ib-IX was dependent upon the modu-
lator, either botrocetin or ristocetin, that was used to facilitate
the interaction (Arya et al., 2002). If we were actually
extracting the receptor, the force observed would be the same
regardless of which modulator was used. It is important to
note that our k0off values are close to the previously reported
k0off values for the A1/ wild-type and mutant GP Ib-IX
interactions; however, our xb values are an order of mag-
nitude greater than the values reported by Kumar and
Doggett. Like the other studies, we are also using the model
employing a single sharp energy barrier. However it is quite
possible that two or more energy barriers exist for the A1/GP
Ib-IX interaction. We surmise that the other studies are pro-
bing the high-strength regime of potentially two energy bar-
riers. This higher energy barrier corresponds to the smaller of
two possible xb values. Using a two barrier system, our k
0
off
values are similar for surpassing both energy barriers, and
thus, we have the same k0off values as the others. However, it
is generally accepted that the slope associated with a high-
strength regime is greater than the slope associated with a
low-strength regime (Evans, 1998). As a result, the xb value
(i.e., the inverse slope) related to the low-strength regime is
greater than the xb value associated with the high-strength
regime. Thus, our xb values, which correspond to the lower-
energy barrier, will be larger than the xb values of others,
which may indeed correspond to the higher-energy barrier.
In addition, one should notice that there appears to be a con-
sistent pattern associated with the deviations of the measured
force values from the ﬁtted values in Fig. 6. Although our
TABLE 1 Dissociation rates and xb values of A1 bonds with
wild-type and mutated GP Ib-IX receptors
Cell type k0off (s
1) xb (nm)
Wild-type 5.47 6 0.25 0.71 6 0.03
231 mutant 7.99 6 0.53 0.97 6 0.06
232 mutant 10.8 6 0.34 1.4 6 0.04
233 mutant 4.07 6 0.31 0.47 6 0.03
235 mutant 3.73 6 0.29 0.44 6 0.03
237 mutant 3.27 6 0.22 0.45 6 0.03
239 mutant 4.21 6 0.38 0.55 6 0.05
Wild-type (Doggett, 2002) 3.45 6 0.37 0.016 6 0.002
Wild-type (Kumar, 2003) 5.66 0.0058
Wild-type (Miura, 2000) 0.0038 —
233 (Doggett, 2003) 0.67 6 0.11 0.031 6 0.005
237 (Kumar, 2003) 2.56 0.0089
For each cell type in our experiments, there were 170 A1/GP Ib-IX
adhesive events and statistically signiﬁcant differences among the k0off
values (p , 0.05).
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group and others investigating the VWF/GP Ib-IX in-
teraction have all used the single sharp energy barrier model,
this consistency suggests a more complicated energy land-
scape with multiple transition states. Using this logic, one
can see why our k0off values are similar to those reported by
others, but our xb values are greater than those previously
reported.
Many similarities exist between the trafﬁcking of cells into
tissues during the immune response and platelet adhesion to
the vessel wall during hemostasis. For example, the three
stages that govern the conversion of an unbound blood cell to
an adherent one under ﬂow conditions in both the immune
response and hemostasis are initial tethering, transient rolling
adhesion, and ﬁrm adhesion. The selectins are critical in
mediating the initial tethering events of leukocytes to the
blood vessel wall during inﬂammation. As suggested by
Doggett et al. (2002), we also believe that the A1/GP Ib-IX
bond does indeed possess kinetic properties similar to the
bonds formed by selectins, and this crucial interaction helps to
promote rapid platelet adhesion to theVWFmatrix under ﬂow
conditions. A previous study using surface plasmon reso-
nance techniques found the unloaded dissociation constant
for the P-selectin/
P-selectin glycoprotein ligand-1 interaction to be ;1.4 s1
(Mehta et al., 1998), which is on the same order as the k0off
value for theA1/GP Ib-IX interaction. This is reasonable since
the selectins are involved in the process of inﬂammation,
similar to the process of hemostasis associated with adhesion
of platelets to vascular surfaces.
One should note that the physiologic shear rates (several
hundred s1) imposed on platelets during the initial phase of
hemostasis are on the same order of magnitude as the higher
loading rates (10,000–20,000 pN/s) used in this study
(Litvinov et al., 2002). It is also important to realize that the
A1/GP Ib-IX rupture values were slightly below 40 pN at a
loading rate as high as 20,000 pN/s. This force value is much
lower than bond strengths as determined by atomic force
microscopy between various integrins and extracellular matrix
proteins (;100 pN), interactions required for irreversible
cell adhesion (Lehenkari and Horton, 1999). Thus this dif-
ference in bond strengths is reasonable since the VWF/GP
Ib-IX interaction is not associated with irreversible platelet
adhesion but rather is responsible for the tethering and rolling
of platelets within the vessel.
Since the pulling rate in some of the trials was 100 mm/s, it
is important to address the importance of inertia and drag on
our observed rupture forces. Ermilov and Anvari have ana-
lyzed the signiﬁcance of inertia and hydrodynamic coupling
on observed forces at different pulling rates (Ermilov and
Anvari, 2004). Their theoretical calculations clearly indicate
that the inertia of a 2-mm polystyrene microsphere is neg-
ligible during an exponential increase of microsphere
velocity from 0 to 1000 mm/s. The inertia is ,5 pN even
when the time constant is 1 ms. Since we are only accel-
erating the bead to a maximum velocity of 100 mm/s, the
inertia is certainly negligible. Also, the time constant for our
system exceeds 1 ms. In addition, the calculations of Ermilov
and Anvari indicate that the drag contributes signiﬁcantly to
the rupture force when the pulling rate is ;1000 mm/s. This
velocity is an order of magnitude greater than the highest
pulling rate used in our study.
One of the primary goals of force spectroscopy studies is
to correlate the structure of a protein to its various biological
functions. The crystal structure of GP Iba indicates the
presence of a b-loop comprising residues 227–241 (Hui-
zinga et al., 2002). Extending over the interior of the GP Iba
leucine-rich repeat concave face, the loop forms a projection
that appears to hinder the binding of the VWF A1 domain.
Thus, a conformational change in the loop may be necessary
for A1/GP Iba binding to occur. Uff et al. (2002) believe the
projection could either fold back and actively promote bind-
ing or simply be removed. Based on our adhesion studies,
individual residues in the region of the loop play a critical
role in binding to A1. We found that valine mutations in
residues 233, 235, 237, and 239 increased the A1/GP Iba
single-bond strength with respect to the wild-type receptor
regardless of loading rate. These GOF mutations lie on the
outer tips of the loop and are most likely promoting a more
open conformation of the glycoprotein (Uff et al., 2002). It is
possible that residues 231 and 232 substantially decreased
the A1/GP Iba bond strength due to steric hindrance. We
surmise that the projection of the loop did not extend out to
a sufﬁcient length in the LOF mutants. Thus, our adhesion
studies indicate that individual amino acid mutations in GP
Iba can dramatically affect the ability of GP Ib-IX to bind
A1, and alter the bond kinetics associated with the VWF/GP
Ib-IX interaction in hemostasis. Future studies should focus
on analysis of the VWF/GP Ib-IX interaction under hydro-
dynamic ﬂow on the single-bond level to further delineate
the molecular aspects of ptVWD.
CONCLUSION
The use of optical tweezers in conjunction with optical
detection of the trapped bead displacement using a quadrant
photodetector allowed us to dynamically monitor unbinding
forces between VWF A1 domain and wild-type or mutant
GP Ib-IX receptor complexes. Based on these measurements
performed at loading rates ranging between 200 and 20,000
pN/s, we observed that single point mutations in the GP Iba
subunit of GP Ib-IX could induce signiﬁcant changes in the
receptor’s ability to bind A1. The unbinding studies dem-
onstrated a logarithmic increase in mutant and wild-type GP
Ib-IX/A1 rupture force as the loading rate increased. Al-
though the detailed structure of the mutant complexes has yet
to be determined, we surmise that changes in the b-loop of
GP Iba are responsible for the increase or decrease in
binding between A1 and the various GP Ib-IX receptors
across all loading rates examined.
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